Improving Clinician and Patient Adherence to Guideline-Recommended Antiplatelet Therapy in ACS: An Interactive Serial-Learning Initiative for Managed Care
Accredited On-Demand Case Vignettes
Jointly sponsored by North American Center for Continuing Medical Education, LLC and Horizon CME
Faculty
Christopher Cannon, MD
Senior Investigator, TIMI Study Group/Brigham & Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
Associate Physician
Cardiovascular Division, Brigham & Women’s Hospital
Boston, Massachusetts
Ty J. Gluckman, MD, FACC
Director, Coronary Care Unit
Providence St. Vincent Heart & Vascular Institute
Portland, Oregon
Target Audience
This activity is designed for managed markets physicians and pharmacists.
Learning Objectives
- Outline the guideline-based role of antiplatelet therapy in the prevention of coronary attacks in patients with acute coronary syndromes (ACS)
- Summarize the clinical profiles of current and emerging antiplatelet therapies
- Describe the cost-effectiveness of antiplatelet therapy in patients with ACS
- Identify barriers to clinician and patient adherence to guideline-based antiplatelet therapy and implement strategies to overcome them
Activity Overview
This on-demand case vignette series consists of 4 patient case studies, with polling questions integrated throughout each case.
To be eligible for documentation of credit, participants must review each case study, answer all polling questions, complete the 5-question online post-test with a score of 60% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
There is no fee associated with this activity.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: April 26, 2010
Expiration Date: April 26, 2011
Estimated time to complete: 1.5 hours
For questions regarding this educational activity, please contact Horizon CME at 503-775-5799.
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of North American Center for Continuing Medical Education, LLC (NACCME) and Horizon CME. NACCME is accredited by the ACCME to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) of continuing pharmacy education (UAN 276-999-10-016-H01-P).
Planning Committee
The planning committee comprises Christopher Cannon, MD, Ty J. Gluckman, MD, FACC, Luis Gruberg, MD, FACC; Elizabeth Hill, Brian Lee, PharmD, Horizon CME; Kristin Dickie, Mary Johnson, Mike Kearney, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.
Faculty Financial Disclosures
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
Faculty |
Disclosure(s) |
Christopher Cannon, MD |
Advisory Board – Automedics Medical Systems Research Grants – Accumetrics, AstraZeneca, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, GlaxoSmithKline, Intekrin Therapeutics, Merck & Co, Inc., Novartis, Takeda Pharmaceuticals North Anerican, Inc. |
Ty Gluckman, MD |
Speaker Bureau – Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Eli Lilly/Daiichi Sankyo Partnership |
Gene Y. Sung, MD, MPH |
Speakers Bureau – Abbott, Eli Lilly and Company |
Off-Label Disclosure
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
The faculty has disclosed that the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of ticagrelor, elinogrel (PRT060128), SCH 530348, E5555, and terutroban (S18886) in the treatment of ACS.
Disclaimer
The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of NACCME or Horizon CME. The information is presented for the purpose of advancing the attendees' professional development.
Planning Committee Disclosures
Ms. Dickie, Ms. Hill, Ms. Johnson, Mr. Kearney, Dr. Lee, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.
Grant Support
This program is supported by an educational grant from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.
Access to Webcast
To access the case vignettes, click on the link below. Once you arrive in the portal, you will be required to complete the registration page. Once you have registered, you will have access to view the case vignettes and complete the post-test and evaluation for CME credit.